Guardian Life Insurance’s Idexx Laboratories IDXX Stock Holding History

Guardian Life Insurance’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-251	Closed	-$66K	–	225
2019 Q4	$66K	Hold	251	–	–	0.02%	263
2019 Q3	$68K	Buy	251 +6	+2%	+$1.67K	0.01%	256
2019 Q2	$67K	Hold	245	–	–	0.01%	260
2019 Q1	$55K	Hold	245	–	–	0.01%	285
2018 Q4	$46K	Buy	245 +5	+2%	+$1.02K	0.01%	287
2018 Q3	$60K	Hold	240	–	–	0.01%	261
2018 Q2	$52K	Buy	240 +40	+20%	+$8.24K	0.01%	282
2018 Q1	$38K	Sell	200 -82	-29%	-$15.1K	0.01%	305
2017 Q4	$44K	Buy	282 +84	+42%	+$13.2K	0.01%	364
2017 Q3	$31K	Hold	198	–	–	﹤0.01%	345
2017 Q2	$32K	Sell	198 -147	-43%	-$23.9K	﹤0.01%	322
2017 Q1	$53K	Buy	+345	New	+$47.6K	0.01%	339

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Guardian Life Insurance's IDXX Position: Q1 2020 in Review

Guardian Life Insurance sold out of Idexx Laboratories (IDXX) in Q1 2020, closing a stake of 251 shares — an estimated $66K sold.

Guardian Life Insurance first reported a position in IDXX in Q1 2017 and held it in 12 quarters. The position peaked at $68K in Q3 2019. 748 funds tracked by Wall St. Rank hold IDXX as of Q1 2020.

Guardian Life Insurance reported no remaining Idexx Laboratories position as of Q1 2020 after selling out during the quarter.
Guardian Life Insurance sold 251 Idexx Laboratories shares in Q1 2020, an estimated $66K.
Guardian Life Insurance first reported a position in Idexx Laboratories in Q1 2017 and held it in 12 quarters.
Guardian Life Insurance's Idexx Laboratories position peaked at $68K in Q3 2019.
748 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2020.

Based on Guardian Life Insurance's 13F filing for Q1 2020.